Analyst Ratings for Oncternal Therapeutics (ONCT) [Neutrals]
ONCT Rating Summary
ONCT Price Target Summary
- Highest: $30.00 (H.C. Wainwright)
- Lowest: $1.30 (Cantor Fitzgerald)
- Average: $11.10
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.10 (+23.3%)
* Over Last 12-Mos
Rating Score: 7.1 / 10 Percentile Rank: 77%
Rating Score: 7.1 / 10 Percentile Rank: 77%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
4/4/2023 | Maxim Group | Naureen Quibria | Downgrade | Hold (Buy) |
N/A (N/A) |
0.79 (9.00) |
1039.24% | Details |
4/4/2023 | Oppenheimer | Hartaj Singh | Downgrade | Perform (Outperform) |
N/A (N/A) |
0.79 (9.00) |
1039.24% | Details |